121 related articles for article (PubMed ID: 28891941)
1. COX Inhibition Profile and Molecular Docking Studies of Some 2-(Trimethoxyphenyl)-Thiazoles.
Oniga SD; Pacureanu L; Stoica CI; Palage MD; Crăciun A; Rusu LR; Crisan EL; Araniciu C
Molecules; 2017 Sep; 22(9):. PubMed ID: 28891941
[TBL] [Abstract][Full Text] [Related]
2. Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations.
Mohammed ER; Abd-El-Fatah AH; Mohamed AR; Mahrouse MA; Mohammad MA
Bioorg Chem; 2024 Jun; 147():107372. PubMed ID: 38653152
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation as well as in silico studies of arylpiperazine-1,2-benzothiazine derivatives as novel anti-inflammatory agents.
Szczęśniak-Sięga BM; Wiatrak B; Czyżnikowska Ż; Janczak J; Wiglusz RJ; Maniewska J
Bioorg Chem; 2021 Jan; 106():104476. PubMed ID: 33250206
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety.
Sağlık BN; Osmaniye D; Levent S; Çevik UA; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2021 Jan; 209():112918. PubMed ID: 33071054
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms in the Selectivity of Nonsteroidal Anti-Inflammatory Drugs.
Shamsudin Y; Gutiérrez-de-Terán H; Åqvist J
Biochemistry; 2018 Feb; 57(7):1236-1248. PubMed ID: 29345921
[TBL] [Abstract][Full Text] [Related]
6. Molecular docking-guided synthesis of NSAID-glucosamine bioconjugates and their evaluation as COX-1/COX-2 inhibitors with potentially reduced gastric toxicity.
Jones Lipinski RA; Thillier Y; Morisseau C; Sebastiano CS; Smith BC; Hall CD; Katritzky AR
Chem Biol Drug Des; 2021 Jul; 98(1):102-113. PubMed ID: 33955172
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Cyclooxygenases Inhibition Activities and Interactions with BSA of
Krzyżak E; Szkatuła D; Wiatrak B; Gębarowski T; Marciniak A
Molecules; 2020 Jun; 25(12):. PubMed ID: 32630594
[TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Silico Evaluation of New 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-
Peregrym K; Szczukowski Ł; Wiatrak B; Potyrak K; Czyżnikowska Ż; Świątek P
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502040
[TBL] [Abstract][Full Text] [Related]
9. COX Inhibition Profiles and Molecular Docking Studies of the Lignan Hinokinin and Some Synthetic Derivatives.
Borges A; Casoti R; E Silva MLA; da Cunha NL; da Rocha Pissurno AP; Kawano DF; da Silva de Laurentiz R
Mol Inform; 2018 Dec; 37(12):e1800037. PubMed ID: 30066986
[TBL] [Abstract][Full Text] [Related]
10. Insight into the Crystal Structures and Potential of Two Newly Synthesized Naproxen-Based Hydrazide Derivatives as Potent COX-2 Inhibitors.
Mohamed SK; Ahmad S; Albayati MR; Elgarhy SMI; Lai CH; Mague JT; El Bakri Y
Appl Biochem Biotechnol; 2022 Dec; 194(12):5781-5807. PubMed ID: 35819690
[TBL] [Abstract][Full Text] [Related]
11. New phenolic cinnamic acid derivatives as selective COX-2 inhibitors. Design, synthesis, biological activity and structure-activity relationships.
Ribeiro D; Proença C; Varela C; Janela J; Tavares da Silva EJ; Fernandes E; Roleira FMF
Bioorg Chem; 2019 Oct; 91():103179. PubMed ID: 31404794
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies.
El-Azab AS; Abdel-Aziz AA; Abou-Zeid LA; El-Husseiny WM; El Morsy AM; El-Gendy MA; El-Sayed MA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):989-998. PubMed ID: 29806488
[TBL] [Abstract][Full Text] [Related]
13. Biological Evaluation and Molecular Docking Studies of Novel 1,3,4-Oxadiazole Derivatives of 4,6-Dimethyl-2-sulfanylpyridine-3-carboxamide.
Świątek P; Glomb T; Dobosz A; Gębarowski T; Wojtkowiak K; Jezierska A; Panek JJ; Świątek M; Strzelecka M
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008977
[TBL] [Abstract][Full Text] [Related]
14. In silico characterisation of olive phenolic compounds as potential cyclooxygenase modulators. Part 1.
Liang J; Bonvino NP; Hung A; Karagiannis TC
J Mol Graph Model; 2020 Dec; 101():107719. PubMed ID: 32898836
[TBL] [Abstract][Full Text] [Related]
15. New
Szczukowski Ł; Krzyżak E; Wiatrak B; Jawień P; Marciniak A; Kotynia A; Świątek P
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681894
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, spectroscopic characterization, molecular docking and theoretical studies (DFT) of N-(4-aminophenylsulfonyl)-2-(4-isobutylphenyl) propanamide having potential enzyme inhibition applications.
Asghar A; Yousuf M; Mubeen H; Nazir R; Haruna K; Onawole AT; Rasheed L
Bioorg Med Chem; 2019 Jun; 27(12):2397-2404. PubMed ID: 30683553
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of key enzymes in the inflammatory pathway by hybrid molecules of terpenes and synthetic drugs: In vitro and in silico studies.
Theoduloz C; Alzate-Morales J; Jiménez-Aspee F; Isla MI; Alberto MR; Pertino MW; Schmeda-Hirschmann G
Chem Biol Drug Des; 2019 Mar; 93(3):290-299. PubMed ID: 30294891
[TBL] [Abstract][Full Text] [Related]
18. Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathways.
das Chagas Pereira de Andrade F; Mendes AN
Sci Rep; 2020 Oct; 10(1):16204. PubMed ID: 33004893
[TBL] [Abstract][Full Text] [Related]
19. Profiling the interaction of 1-phenylbenzimidazoles to cyclooxygenases.
Gómez-Castro CZ; López-Martínez M; Hernández-Pineda J; Trujillo-Ferrara JG; Padilla-Martínez II
J Mol Recognit; 2019 Nov; 32(11):e2801. PubMed ID: 31353677
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of vortioxetine derivatives as new COX-1/2 inhibitors in human monocytes.
Talmon M; Chaudhari RD; Suryavanshi H; Chowdhury N; Quaregna M; Pin A; Bagchi A; Biswas G; Fresu LG
Bioorg Med Chem; 2020 Dec; 28(23):115760. PubMed ID: 32992247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
